Does change in cognitive function predict change in costs of care for people with a schizophrenia diagnosis following cognitive remediation therapy?

Schizophrenia Bulletin

Volumn 40, Issue 6, 2014, Pages 1472-1481

  Reeder, Clare ^a   Harris, Victoria ^a   Pickles, Andrew ^a   Patel, Anita ^a   Cella, Matteo ^a   Wykes, Til ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

cognition; cognitive predictors; executive function; functioning; working memory

Indexed keywords

ARTICLE; COGNITION; COGNITIVE THERAPY; DAY CARE; DEPRESSION; DISABILITY; DISEASE ASSOCIATION; EXECUTIVE FUNCTION; FOLLOW UP; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SOCIAL CARE; ADULT; COST OF ILLNESS; ECONOMICS; FEMALE; MALE; MIDDLE AGED; NURSING; OUTCOME ASSESSMENT; PHYSIOLOGY; PROCEDURES;

ADULT; COGNITIVE THERAPY; COST OF ILLNESS; EXECUTIVE FUNCTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SCHIZOPHRENIA;

EID: 84913539775     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbu046     Document Type: Article

References (50)

1. Wittchen HU, Jacobi F, Rehm J, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:655-679.
2. Gustavsson A, Svensson M, Jacobi F, et al.; CDBE2010Study Group. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718-779.
3. Harvey PD, Strassnig M. Predicting the severity of everyday functional disability in people with schizophrenia: cognitive deficits, functional capacity, symptoms, and health status. World Psychiatry. 2012;11:73-79.
4. Rethink. Effective Interventions for Schizophrenia - The Economic Case. London, UK: Rethink; 2012.
5. Heinrichs RW, Zakzanis KK. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology. 1998;12:426-445.
6. Tsang HW, Leung AY, Chung RC, Bell M, Cheung WM. Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998. Aust N Z J Psychiar. 2010;44:495-504.
7. Bell M, Bryson G, Greig T, Corcoran C, Wexler BE. Neurocognitive enhancement therapy with work therapy: effects on neuropsychological test performance. Arch Gen Psychiatry. 2001;58:763-768.
8. McGurk SR, Mueser KT, DeRosa TJ, Wolfe R. Work, recovery, and comorbidity in schizophrenia: a randomized controlled trial of cognitive remediation. Schizophr Bull. 2009;35:319-335.
9. Peña J, Segarra R, Ojeda N, García J, Eguiluz JI, Gutiérrez M. Do the same factors predict outcome in schizophrenia and non-schizophrenia syndromes after first-episode psychosis? A two-year follow-up study. J Psychiatr Res. 2012;46:774-781.
10. Hoe M, Nakagami E, Green MF, Brekke JS. The causal relationships between neurocognition, social cognition and functional outcome over time in schizophrenia: a latent difference score approach. Psychol Med. 2012;42:2287-2299.
11. Wykes T. Predicting symptomatic and behavioural outcomes of community care. Br J Psychiatry. 1994;165:486-492.
12. Lin CH, Huang CL, Chang YC, et al. Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia. Schizophr Res. 2013;146:231-237.
13. Jeste SD, Patterson TL, Palmer BW, Dolder CR, Goldman S, Jeste DV. Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia. Schizophr Res. 2003;63:49-58.
14. Okonkwo OC, Griffith HR, Copeland JN, et al. Medical decision- making capacity in mild cognitive impairment: a 3-year longitudinal study. Neurology. 2008;71:1474-1480.
15. Bambauer KZ, Soumerai SB, Adams AS, Zhang F, Ross- Degnan D. Provider and patient characteristics associated with antidepressant nonadherence: the impact of provider specialty. J Clin Psychiatry. 2007;68:867-873.
16. Reeder C, Newton E, Frangou S, Wykes T. Which executive skills should we target to affect social functioning and symptom change? A study of a cognitive remediation therapy program. Schizophr Bull. 2004;30:87-100.
17. Reeder C, Smedley N, Butt K, Bogner D, Wykes T. Cognitive predictors of social functioning improvements following cognitive remediation for schizophrenia. Schizophr Bull. 2006;32(suppl 1):S123-S131.
18. Mackin RS, Delucchi KL, Bennett RW, Areán PA. The effect of cognitive impairment on mental healthcare costs for individuals with severe psychiatric illness. Am J Geriatr Psychiatry. 2011;19:176-184.
19. Patel A, Everitt B, Knapp M, et al. Schizophrenia patients with cognitive deficits: factors associated with costs. Schizophr Bull. 2006;32:776-785.
20. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168:472-485.
21. Wykes T, Reeder C, Landau S, et al. Cognitive remediation therapy in schizophrenia: randomised controlled trial. Br J Psychiatry. 2007;190:421-427.
22. Wykes T, Reeder C, Williams C, Corner J, Rice C, Everitt B. Are the effects of cognitive remediation therapy (CRT) durable? Results from an exploratory trial in schizophrenia. Schizophr Res. 2003;61:163-174.
23. Eack SM, Greenwald DP, Hogarty SS, et al. Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial. Psychiatr Serv. 2009;60:1468-1476.
24. Spaulding WD, Reed D, Sullivan M, Richardson C, Weiler M. Effects of cognitive treatment in psychiatric rehabilitation. Schizophr Bull. 1999;25:657-676.
25. Wykes T, Reeder C, Huddy V, et al. Developing models of how cognitive improvements change functioning: mediation, moderation and moderated mediation. Schizophr Res. 2012;138:88-93.
26. Wykes T, Sturt E. Social behaviour schedule [SBS]. In: Wade DT, ed. Measurement in Neurological Rehabilitation. New York, NY: Oxford University Press; 1992:283-284.
27. Wilson B, Cockburn J, Baddeley A. Rivermead Behavioural Memory Test. Bury St. Edmonds, UK: Thames Valley Test Company; 1985.
28. Heaton R, Chelune G, Talley J, Kay G, Curtiss G. Wisconsin Card Sorting Test Manual: Revised and Expanded. Odessa, FL: Psychological Assessment Resources, Inc; 1993.
29. Burgess PW, Shallice T. The Hayling and Brixton Tests. Bury St. Edmonds, UK: Thames Valley Test Company/Pearson Assessment; 1997.
30. Nelson H, Willison J. National Adult ReadingTest (NART): Test Manual. 2nd ed. London, UK: Nfer Nelson; 1991.
31. Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-276.
32. Wilson B, Alderman N, Burgess P, et al. Behavioural Assessment of the Dysexecutive Syndrome BADS. Bury St. Edmonds, UK: Thames Valley Test Company; 1996.
33. Wykes T, Sturt E, Katz R. The prediction of rehabilitative success after three years. The use of social, symptom and cognitive variables. Br J Psychiatry. 1990;157:865-870.
34. Trenerry M, Crosson B, DeBoe J, Leber W. The Stroop Neuropsychological Screening Test. Odessa, FL: Psychological Assessment Resources; 1989.
35. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation; 1997.
36. Benton A, Hamsher K, Sivan A. Multilingual Aphasia Examination. Iowa City, IA: AJA Associates; 1994.
37. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261-276.
38. Beecham JK, Knapp M. Costing psychiatric interventions. In: Thornicroft G, Brewin C, Wing JK, eds. Measuring Mental Health Needs. London: Gaskell; 1992:163-183.
39. Netten A, Rees T, Harrison G. Unit Costs of Health and Social Care. Canterbury, Kent: University of Kent at Canterbury, PSSRU; 2001. OECD. Purchasing Power Parities. Comparative Price Levels. http://www.oecd.org/dataoecd/61/54/18598754.pdf. Accessed October 14, 2004.
40. Joint Formulary Committee. British National Formulary. 44th ed. London, UK: British Medical Association and Royal Pharmaceutical Society of Great Britain; 2002. http://www.bnf.org/bnf/. Accessed February 7, 2003.
41. CIPFA. Education Statistics 1999-2000 Actuals. London, UK: Chartered Institute of Public Finance and Accountancy; 2000.
42. Department for Work and Pensions 2003. Benefits and services. http://webarchive.nationalarchives.gov.uk/+/http://www.dwp.gov.uk/lifeevent/benefits. Accessed March 17, 2014.
43. Finn W, Hyslop J, Truman C. Mental Health Multiple Needs and the Police. London, UK: Revolving Doors Agency; 2000.
44. Delahunty A, Reeder C, Wykes T, Morice R, Newton E. Revised Cognitive Remediation Therapy Manual. London, UK: Institute of Psychiatry; 2002.
45. Coid JW, Kirkbride JB, Barker D, et al. Raised incidence rates of all psychoses among migrant groups: findings from the East London first episode psychosis study. Arch Gen Psychiatry. 2008;65:1250-1258.
46. Liu SK, Chiu CH, Chang CJ, Hwang TJ, Hwu HG, Chen WJ. Deficits in sustained attention in schizophrenia and affective disorders: stable versus state-dependent markers. Am J Psychiatry. 2002;159:975-982.
47. Rose D, Wykes T, Farrier D, Doran AM, Sporle T, Bogner D. What do clients think of cognitive remediation therapy? A consumer-led investigation of satisfaction and side effects. Am J Psychiatr Rehabil. 2008;11:181-204.
48. Wykes T, Reeder C, Corner J, Williams C, Everitt B. The effects of neurocognitive remediation on executive processing in patients with schizophrenia. Schizophr Bull. 1999;25:291-307.
49. Wykes T, Reeder C. Cognitive Remediation Therapy for Schizophrenia: Theory and Practice. London, UK: Brunner Routledge; 2005.
50. Vinogradov S, Fisher M, de Villers-Sidani E. Cognitive training for impaired neural systems in neuropsychiatric illness. Neuropsychopharmacology. 2012;37:43-76.